Clinical Trial

Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The clinical study aims to evaluate the safety and efficacy of umbilical cord blood transfusion in treating bone marrow suppression after chemotherapy in elderly patients with MDS and AML
Trial Details
NCT Number NCT07201233
Lead Sponsor Shandong Qilu Stem Cells Engineering Co., Ltd.
Collaborators: Tianjin Medical University General Hospital
Conditions Bone Marrow Suppression
Enrollment 30 participants
Start Date 2025-11-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-01